Full index of posts »
NVIV - adding here at $1.89 (1/7 gap fill) in advance of imminent news of human trial commencement. NVIV article to be published this week. Feb 12, 2013
GLUU, pre-earnings analyst action, Roth, BUY, $4.00 PT; Northland, Market Perform, $3.00 PT Feb 4, 2013
- JoeNatural on Why YELP May Settle With Blue Calypso Over Patent Infringement Great article as always Natty. Looks like the d...
- forever_opimistic on ACUR News: Top 3 National Drug Wholesalers To Distribute Acura's NEXAFED Nexafed is now for sale at Kroger retail pharma...
- dwdallam on ACUR News: Top 3 National Drug Wholesalers To Distribute Acura's NEXAFED Why don't they release this information on the ...
- Adam Gefvert on ACUR News: Top 3 National Drug Wholesalers To Distribute Acura's NEXAFED Thanks. How old are those distribution agreements?
- theraiderofthelostpark on GLUU Technical Analysis Says 86% Pop To $7.79 By October 3 Can you update this broken model please?